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Abstract: Fibrous materials have garnered much interest in the field of biomedical engineering
due to their high surface-area-to-volume ratio, porosity, and tunability. Specifically, in the field of
tissue engineering, fiber meshes have been used to create biomimetic nanostructures that allow for
cell attachment, migration, and proliferation, to promote tissue regeneration and wound healing,
as well as controllable drug delivery. In addition to the properties of conventional, synthetic polymer
fibers, fibers made from natural polymers, such as proteins, can exhibit enhanced biocompatibility,
bioactivity, and biodegradability. Of these proteins, keratin, collagen, silk, elastin, zein, and soy are
some the most common used in fiber fabrication. The specific capabilities of these materials have
been shown to vary based on their physical properties, as well as their fabrication method. To date,
such fabrication methods include electrospinning, wet/dry jet spinning, dry spinning, centrifugal
spinning, solution blowing, self-assembly, phase separation, and drawing. This review serves to
provide a basic knowledge of these commonly utilized proteins and methods, as well as the fabricated
fibers’ applications in biomedical research.
Keywords: protein; nanofibers; biomaterials fabrication; medicine; tissue engineering; wound healing;
drug delivery
1. Introduction
Fibrous materials, so often used in industrial applications and the textile industry, have now
migrated into biomedical research. To date, polymer-based fibers with diameters on the micro- or
nanoscale have been explored in drug delivery [1–4], wound healing [5–7], tissue engineering [8–10],
and biosensor technologies [11–13] due to their high surface-area-to-volume ratio, mechanical strength,
porosity, potential for surface modification, and tunability [13–15]. Equally important in biomaterials
engineering, however, is the need for materials to be both biocompatible and biodegradable. Therefore,
to maximize these properties, natural polymer-based fibers made from proteins have begun to be
developed [16–19].
The appeal of protein-based fibers for biomedical applications stems from the fact that many
proteolytic enzymes capable of degrading commonly used natural polymers are already present in the
body. In the case of protein-based biomaterials, degradation of these materials leads to the production
of amino acids that pose no risk of toxicity and can be reabsorbed by the body [20,21]. In the field of
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tissue engineering, this avoidance of toxic byproducts is of particular importance since materials must
degrade and be replaced by native tissue to achieve complete regeneration [22]. In the field of drug
delivery and nanomedicine, protein-based nanofibers may have the ability to store pharmaceutical
products and biological molecules without threatening their bioactivity [23–25]. Their controllable
degradation through crosslinking or post-fabrication modifications has also been shown to allow
for the controllable release of drugs, with no added toxicity from material byproducts during
fabrication [26,27]. Blending of proteins with other natural and synthetic polymers can also allow for
the development of versatile materials with modifiable degradation and physical properties [28,29].
The biodegradable nature of protein-based fiber materials also supports the efforts of green and
sustainable engineering. Such applications reduce the dependence on petroleum-based polymers
avoiding the pollution issues caused by the disposal of these materials and their byproducts [30].
Additionally, many proteins, such as silk, soy, and corn zein, are very abundant and easy to isolate [31].
The incorporation of natural polymers in biomaterials has also been shown to enhance cell
attachment due to the presence of native cell attachment motifs [25,32]. Thus, the use of protein-based
fibers in tissue engineering and nanomedicine has both medical and commercial appeal. Despite these
advantages, however, standardization of the mechanical and physical properties of protein-based
fibers remains challenging. Such materials have been shown to vary depending on the method of
fiber production, the fiber diameter, and the composition of the fiber [33–35]. In order to illustrate
the appeal of protein-based fibers and regulate their use, this review serves to provide a basic
knowledge of the commonly used materials and methods for the fabrication of protein-based fibers
and their corresponding use in tissue engineering, wound healing, and drug delivery. Popular proteins,
such as keratin, collagen, silk, elastin, zein, and soy, are given particular attention, as well as current
fabrication methods, including electrospinning, wet/dry jet spinning, dry spinning, centrifugal
spinning, solution blowing, self-assembly, phase separation, and drawing.
2. Protein Materials
Some of the specific types of proteins that will be discussed include keratin, collagen, silk, elastin,
zein, and soybean (Figure 1). These proteins are some of the most common protein polymers used for
the fabrication of fibers for biomedical application.
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Figure 1. Protein-based biomaterials can be made from a variety of sources. The origin and structures
of some of the most commonly used proteins are shown. These include collagen or gelatin, silk, keratin,
elastin, soy, and corn zein. These proteins can then be processed into fibers with unique physical
properties through a variety of methods.
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2.1. Elastin
Elastin is a naturally-occurring protein found in the extracellular matrix (ECM) that maintains the
elasticity of connective tissue in the human body. Tropoelastin, the 72 kDa precursor to elastin, is first
synthesized by cells in the rough endoplasmic reticulum and consists of alternating hydrophobic
and hydrophilic domains. The hydrophilic domains contain lysine residues interspersed by alanine
residues, and this arrangement allows for tetrafunctional crosslinking of tropoelastin molecules by the
lysine oxidase enzyme. Crosslinking of tropoelastin molecules is further strengthened by self-assembly
of the hydrophobic domains that consist of repeating motifs of non-polar residues of glycine, valine,
and proline [36]. Complete assembly of elastin molecules occurs outside of cells due to the protein’s
large size. Tropoelastin molecules are believed to align and crosslink after interacting with extracellular
microfibrils near the cell surface. While these microfibrils provide an integral framework for elastin
assembly, as elastin-rich tissue forms, these microfibrils become detectable only on the periphery of the
protein structures [37]. The elastin-based fibers are then arranged in a variety of structures depending
on the tissue’s location. For example, in ligaments, elastin fibers are arranged in parallel-oriented
structures, but can be found in a honeycomb-like pattern in cartilage [36].
In biomaterials engineering, elastin is used to describe a variety of elastic proteins and peptides
rather than one single molecule. It can be used in a variety of forms that include, most commonly,
soluble elastin [18,38,39], recombinant tropoelastin [40,41], and synthetic elastin-like peptides that
may also be hybrids with other proteins, such as silk [42–45]. The inclusion of elastin in nanofiber
scaffolds has been shown to increase fiber elasticity and provide for better cell attachment [18]. Due to
elastin’s elasticity and resilience, it has found special purpose in the development of vascular grafts,
since fibrous scaffolds made from the protein have been shown to closely match the compliance of
natural arteries [46–48].
2.2. Collagen and Gelatin
Collagen is a fibrous protein that serves as the main component of the ECM. While the majority of
collagen found in body can be classified as type I, II, or III, as many as 29 different types of collagen have
been identified. All collagen exhibits a repeating X-Y-Gly amino acid sequence, where glycine is always
present as the third residue. X and Y can denote any amino acids, with proline and hydroxyproline
being the most common ones. The glycine residue allows for a stable secondary structure formation of
collagen, which consists of three strands coiled around each other to form a triple helix. These triple
helices can then arrange into different quaternary structures depending on the type of collagen.
In fibrillar types, such as types I–III, V, and XI, the coiled coils are crosslinked by the lysine oxidase
enzyme to form fibrils that then aggregate to form fibers [49]. The spaces between collagen crosslinking
domains measures 67 nm and these gaps give collagen its striated appearance [50].
Due to its natural abundance, Type I collagen is the most common class of collagen used in
biomaterials development [49]. The production of collagen fibers has allowed for the generation of
biomimetic tissue engineering scaffolds that closely resemble the natural ECM. Therefore, fiber meshes
have been used for bone [51–53], cartilage [54], vasculature [55,56], ligament [57,58], skin [59,60],
muscle [61], and nerve [62,63] regeneration. These materials allow for cell attachment, penetration,
and proliferation due to collagen’s ability to interact with cell surface receptors, such as the α2β1,
α1β1, α10β1, and α11β1 integrins [64]. The mechanical properties of collagen-based fiber meshes can
also be easily modified by chemical or physical crosslinking, although this has been shown to affect
their biocompatibility [65].
Due to its complicated hierarchical structure, collagen fibrils can be difficult to extract and isolate.
However, the coiled coil can be easily broken down through hydrolysis to produce three polypeptide
strands, known as gelatin [66]. These strands can be further degraded into shorter amino acid sequences
by matrix metalloproteinases, making gelatin a biodegradable material with low immunogenicity.
Due to the presence of alkaline and acidic amino acid residues, gelatin is also amphoteric and
can form a thermally reversible network in water [67]. Like collagen, the mechanical properties
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of gelatin-based materials can be further modified through chemical or physical crosslinking, which is
often necessary due to the instability of the natural biopolymer in water at body temperature [68].
Crosslinked gelatin-based materials and fibers made by dissolving gelatin in polar solvents to prevent
aggregation [69] have been shown to promote ocular [70,71], bone [72,73], cardiovascular [74,75],
nerve [76,77], and skin [78] regeneration.
2.3. Silk
Silk is a natural biopolymer produced by insects, spiders, and worms that consists of two main
proteins. Silk sericin, the sticky protein found on the outside of silk strands, makes up 15–35% of silk
cocoons and must be removed through a degumming process to extract the more versatile silk fibroin
protein [79]. The particular amino acid sequence of silk fibroin can vary depending on its species,
but is predominately composed of hydrophobic blocks composed of glycine, alanine, and serine
residues and hydrophilic blocks consisting of charged amino acids. The hydrophobic blocks allow for
the formation of β-sheets within the protein, giving silk high tensile strength, while the hydrophilic
blocks give silk fibroin its elasticity [80]. Variations in specific sequences account for differences in
the secondary structure of silk, which, in turn, affects its mechanical properties, thermal stability,
chemical characteristics, and solubility [79,81].
Silk fibroin obtained from the Bombyx mori silkworm is one of the most commonly used
biomaterials due to its availability and low cost [29,79]. It has been shown to exhibit excellent
biocompatibility, bioactivity, biodegradability, tunability, mechanical stability, and low immunogenicity,
allowing silk-based fibers to be used to create tissue engineering scaffolds that allow for bone [82–85],
cartilage [86], heart valve [87], and nerve [88] regeneration. The oxygen and water vapor permeability
of silk also encourages its use in wound healing [25,89]. The mechanical properties and stability
of silk-based biomaterials can also be modified through methanol treatments that increase β-sheet
crystallinity and strength [29,90].
In addition to silk produced from worms, dragline silk produced by the Nephila clavipes spider has
found use in biomaterials development. Like silkworm silk, it has shown low immunogenicity,
high tensile strength, and biodegradibility. Recent studies have outlined the dragline silk’s
ability to promote cell adhesion, migration, and proliferation of dental pulp stem cells [91] and
cardiomyocytes [92], showing its promise as a component in tissue engineering scaffolds.
2.4. Keratin
Keratin is an insoluble structural protein that makes up the bulk of the adnexa of the epidermis,
including hair, horns, and fingernails. The protein can be further characterized a soft or hard keratin
depending on its amino acid sequence. Both soft and hard keratin, however, have similar secondary
structures that consist of two chains, each containing a central alpha-helical domain. These chains are
designated as type I and II and interact to form heterodimers that polymerize to form filaments [93].
Some forms of keratin, like that found in hair, have a high content of cysteine residues that interact
through disulfide bonding, enhancing the mechanical strength of the protein [94]. Extraction of keratin
requires disruption of these disulfide bonds. This can be accomplished through an oxidation of the
protein [95].
The presence of cell binding motifs on keratin, as well as its ability to self-assemble, make it an
ideal natural polymer to be used in the creation of biomaterials for tissue regeneration [93]. However,
because keratin is known to exhibit poor mechanical stability, it is often combined with other natural or
synthetic polymers to create composite fibers [96,97]. Such composites have been used for the skin [98],
cartilage [99], and bone [97,100] tissue regeneration.
2.5. Zein
Zein is the major storage protein in corn and is a member of the prolamin group of proteins.
Its structure and solubility are dictated by its amino acid sequence, which primarily consists of
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non-polar, uncharged residues, such as glutamine, leucine, proline, and alanine. In addition to its
biodegradability and biocompatibility, recent studies suggest that corn zein can exhibit anti-oxidative
and antimicrobial properties [101,102]. These properties have led to zein’s expanded use in
biomedical engineering.
Studies have shown that the corn protein is compatible with human umbilical vein endothelial
cells, human hepatocytes, and mice fibroblasts [103]. Neat zein nanofibers have been shown to exhibit
low mechanical strength and stability, and the high hydrophobicity of the protein may also prevent
cell attachment [104–106]. Therefore, it is often necessary to incorporate additional synthetic or natural
polymers and chemical crosslinking to create successful tissue engineering scaffolds. Studies suggest
that these composites may promote successful tissue regeneration when used as a scaffold [107,108].
While it may be counter to cell attachment, the hydrophobicity of corn zein does enhance its capabilities
as a drug delivery vehicle since it is more resistant to hydrolysis, allowing for longer, more sustained
release of pharmaceuticals [109,110].
2.6. Soybean Protein
Soybean protein is a globular protein composed of two main subunits referred to as conglycinin
7S and glycinin 11S. Both subunits contain regions of non-polar amino acids, such as alanine, valine,
and leucine; basic amino acids, including lysine and arginine; and non-charged polar residues,
like cysteine and glycine. The globular structure of soybean protein makes it resistant to hydrolysis
and incredibly stable, leading to its long shelf-life [111]. For biomaterials engineering, the protein is
of particular interest due its abundance of functional groups that allow for surface modification and
blending with other polymers [112].
Soy protein is biodegradable and can be obtained from abundant renewable resource. In recent
years, soybean products, such as soybean whole fat (SF), soy protein concentrate (SPC), and soy
protein isolate (SPI), have become alternatives to petroleum polymers due to their abundance and
adhesive properties [113]. Compared to other plant protein-based membranes, SPI-based materials
are clearer, smoother, more flexible, and have impressive gas barrier properties compared to lipid and
polysaccharide formulations.
Although the solubility of soybean protein is relatively low in acidic solutions, solvents with
higher pH above 4.8 have been used to process soybean, allowing for fiber fabrication [114]. Due to
the presence of ECM-mimetic peptides within the protein, such fibers have seen great success as tissue
engineering scaffolds [111]. Some of the most common applications of soy protein materials include
skin regeneration and wound healing [115–117].
3. Fabrication Methods
There are numerous ways of fabricating protein-based fiber materials. Table 1 lists fabrication
methods along with controlled parameters that affect fiber properties.
Table 1. Parameters of fabrication methods affecting fiber properties [118–130].
Fiber Fabrication Method























Dry Spinning - Polymer concentration- Molecular weight
- Post-drawing
- Take up speed
- Temperature
- Humidity
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Table 1. Cont.
Fiber Fabrication Method



















- Solvent evaporation rate
- Molecular weight
- Injection rate
- Gas flow pressure




Electrospinning is a nanofiber fabrication method that consists of three main components:
a polymer solution within a metal tipped syringe, an applied high voltage, and a grounded
collector [131–137]. Figure 2 shows two common electrospinning systems (vertical and horizontal
electrospinning systems) utilized in current research. In the vertical system, gravity is an important
parameter for controlling fiber formation, while horizontal spinning system relies mainly on the
electrical force between the spinning device and the collector.
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electrospinning system.
Before the electrospinning process, polymers are dissolved into a solvent and the solution is
placed inside the syringe. To begin the process, the soluti n is forced out of the syringe at constant
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flow rate. Simultaneously, a high voltage is applied to the solution, resulting in repulsive interactions
between like charges within the solution. A Taylor cone [138] is formed at the end of the syringe when
the electrical forces and surface tension forces in the solution are at equilibrium. At a critical value,
the electrical forces overcome the surface tension forces and a jet of solution propels out of the Taylor
cone and towards the grounded collector. At ideal conditions, as the solution jet travels, the solvent
evaporates from the solution, leaving non-woven, polymer fibers due to high surface area to volume
ratio, and finally gathered on the collector [131–137]. Fibers are produced with diameters in the range
of 10 nm–10 µm, and various collector modifications can also allow the formation of aligned nanofiber
arrays and non-woven yarns. In the literature, numerous protein nanofibers have been fabricated
using the electrospinning technique. Generated fiber mats for silk, collagen, and gelatin-based fibers
are shown in Figure 3 at various scales.
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Figure 3. Scanning electron icroscope i ages of (A) pure silk nanofibers, (B) PCL-gelatin nanofibers,
(C) silk-PE nanofibers, and ( ) type I collagen nanofibers fabricated using the electrospinning
technique (reproduced ith per ission from [19,78,136,139], copyright Elsevier, 2017 (A); Elsevier,
2007 (B); John iley and Sons, Inc., 2010 (C); Elsevier, 2006 ( )).
Electrospinning is a simple, reliable process that produces fibers with controllable properties.
The process is able to produce a versatile range of fibers, including polymer-, synthetic-,
and composite-based fibers [131,134]. The properties of the fibers can be influenced by controlling
different parameters. These parameters can be categorized into three types: solution, process,
and ambient [131,134]. Table 1 lists controllable parameters in their respective categories. Reproducibility
and functionalization of protein-based nanofibers may be enhanced by treating the protein prior
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to fabrication. This approach was adopted by Pegg et al. [140] to produce alginic acid nanofibers.
Prior to spinning, the alginic acid was converted to ammonium alginate by reacting the polymer with
amine-containing cargo. This pre-treatment allowed for more uniform functionalization and enabled the
fibers to carry diverse therapeutics, such as lidocaine, neomycin, and papain. Electrospun nanofibers like
these are also useful in a variety of applications due to their high surface-area-to-volume ratio [131,134]
and modifiable surface porosity [134].
3.2. Wet/Dry-Jet Spinning
Wet spinning is a fiber fabrication method that consists of a polymer solution, a spinneret, and a
coagulation bath (Figure 4A). During the fabrication process, the polymer solution is extruded via
a syringe pump through the spinneret directly into a coagulation bath. Polymer fibers form in
the coagulation bath as the solvent is removed either through chemical reaction or diffusion [141].
After formation, the remaining fiber material is collected and dried. Drawing, or applying tension
to the fibers can occur immediately after the spinneret [141], during drying [125], or further down
the spinning line [142,143] to elongate the fiber, increase molecular alignment and, consequently,
stiffness and strength. Wet spinning fabrication systems may implement multiple drawings or baths in
order to improve molecular alignment and orientation.
A modified version of wet spinning, referred to as dry-jet wet spinning has been developed
(Figure 4B) [124,141,142]. In dry-jet wet spinning, the polymer solution is extruded through an air gap
before the coagulation bath, rather than directly into the bath. Studies have shown that dry-jet wet
spinning can result in greater molecular alignment compared to conventional wet spinning [142].
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Figure 4. Common systems of (A) wet spinning, and (B) dry-jet wet spinning. In dry-jet wet spinning,
the polymer solution is extruded through an air gap before the coagulation bath, resulting in higher
molecular alignment compared to conventional wet spinning [124,141,142].
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By controlling parameters, such as the diameter of the spinneret, polymer solution concentration,
and flow rate, fiber properties, such as diameter, orientation, and morphology [122,125,141,143], can be
modified. Unlike in electrospinning, the fibers are not exposed to a high voltage that may denature
natural polymers, such as proteins. Additionally, drawing of the fibers after formation can lead to
enhanced material properties due to higher molecular alignment. However, the wet/dry spinning
methods typically produces only micron-sized fibers, while electrospinning is a common method of
producing nanofibers.
3.3. Dry Spinning
Dry spinning is a fiber fabrication method that consists of a polymer solution, a syringe, and a
collector. Figure 5A shows the scheme of a typical dry spinning system. Unlike other solution spinning
methods, such as electrospinning and wet spinning, dry spinning involves a single extrusion step.
A key part of the method is that the polymer/protein solution is created such that the solvent of the
solution will evaporate in the ambient environment during spinning. During the process, the solution
is pumped through a syringe and spinneret. Ideally, the solvent of the solution will evaporate out of
the solution, leaving only the polymer fiber to be collected. The fibers are then collected via a take-up
device similar to those used in the wet spinning processes [126]. Similar to wet spinning, additional
drawing [144], heating, or drying [126] can occur to increase the mechanical properties or ensure
fiber stability.
The mechanical properties of the fiber can be affected controlling take up speed, length to
diameter ratio of the spinneret, environment or temperature, and spinning rate [126,145]. Additionally,
subjecting the dry-spun fiber to a post-treatment agent or post-formation drawing can enhance
mechanical properties [126].
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3.4. Centrifugal Spinning
Centrifugal spinning is a process commonly used in the industrial production of fiberglass.
More recently the process has gained traction as a fabrication method of polymer fibers [129]. It exhibits
some significant advantages over the more commonly practiced electrospinning method. Namely,
its comparatively high production rate and its lack of dependence on a voltage resulting in greater
safety [128,129]. A biopolymer solution or melt can be placed in a rotating head with a small opening
referred to as the nozzle. When the head is rotated at a speed that exerts a centrifugal force on the
solution or melt higher than its surface tension, the solution or melt will emerge from the nozzle as a
liquid jet. The liquid jet is stretched by the combination of the centrifugal force and the air friction
force and deposited into a collection area. Solidified fibers with diameters ranging from hundreds
of nanometers to tens of micrometers are produced upon the evaporation of the solvent [129,147].
A process of nozzle-free centrifugal spinning has been tested by Weitz et al., resulting in fibers as
small as 25 nm in diameter [148]. The viscosity, surface tension, molecular structure, molecular weight,
polymer concentration, solvent structure, solvent evaporation rate, and additive of the polymer
solution or melt all contribute to the morphology of the fibers, with viscosity and surface tension
being the largest influences [128,129]. Rotational speed, head diameter, nozzle diameter, and distance
between the nozzle and collector also largely influence the morphology of the fibers produced [129].
3.5. Solution Blowing
Solution blowing is a relatively new method of fiber fabrication. It involves an apparatus
consisting of two concentric nozzles. A biopolymer solution is pumped through the inner nozzle
as a high velocity gas flows through the outer nozzle. The flow of gas stretches the solution and
ejects it from the apparatus. Fibers are formed in the air as the solvent evaporates before reaching a
collector [149]. The high velocity gas is supplied from a source of compressed gas such as nitrogen,
argon, or air equipped with a pressure regulator and connected to the apparatus. Biopolymer type,
concentration, injection rate, gas flow pressure, and working distance all influence the properties of
the fibers being produced [130].
3.6. Self-Assembly
Molecular self-assembly is a process ubiquitous in natural biological systems. Structures formed
by self-assembly are governed by non-covalent forces, such as hydrogen bonding, electrostatic
interactions, van der Waals interactions, hydrophobic interactions, stacking interactions,
and water-mediated hydrogen bonding [150,151]. These non-covalent bonds between small molecules
result in supramolecular architectures, such as nanofibers. The shapes and properties of resulting
fibers are determined by the molecules and non-covalent bonds structuring them [152]. The driving
intermolecular interactions can be influenced by environmental factors, such as salt concentration,
pH, temperature, and surface characteristics [153].
3.7. Phase Separation
Phase separation is a rather simple process. However, it is limited to the scale of a laboratory
setting [152]. The process begins with the dissolution of a protein polymer in a solvent. The temperature
of the solution is then reduced to the gelation temperature, which is the point at which the solution
forms a gel. Solvent exchange is carried out by immersing the gel in distilled water. When removed,
the gel is blotted with filter paper and freeze-dried, resulting in the formation of a nanofibrous
matrix [152]. By adjusting factors, such as gelation temperature and biopolymer concentration,
the morphology of the fibers is able to be controlled [154].
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3.8. Drawing
The commonly used fabrication method, electrospinning, produces a layer of fibers on a flat
collector [155], while the fabrication method known as drawing only produces one fiber at a time.
The production of single fibers limits the use of this method to the laboratory scale [152]. In the
drawing process, a sharp-tipped probe is placed in contact with a droplet of biopolymer solution
and withdrawn at a predetermined speed. The solvent evaporates due to the high surface area in
relation to the volume. The end of the resulting fiber attached to the probe can then be connected to
another droplet to form a suspended fiber [146]. The drawing process relies on the viscoelasticity of
the solution so that it can maintain cohesion under the stresses of being pulled [156]. Multiple fibers
can be drawn from each droplet [152]. When too much time is allowed to pass between the deposition
of the solution droplet and the drawing of the fiber, the droplet will become too viscous due to the
evaporation of the solvent. Furthermore, the continual shrinkage of the droplet affects the diameter
of the fibers produced and limits the continuous drawing of fibers. A modification to this method,
implementing the use of micropipettes, can improve the continuous formation of short fibers and
provide greater control of the parameters that affect fiber properties. In this method the solution is
continuously pumped through the micropipette. The droplet is formed at the tip of the micropipette
and brought in contact with a substrate that it will adhere to. It is then laterally drawn before coming
in contact with the substrate once again, forming a suspended fiber [146].
4. Applications of Protein-Based Nanofibers in Tissue Regeneration and Nanomedicine
Many protein-based fiber materials have applications in the biomedical field. These materials have
been put to use, in part, because of their favorable biocompatible and biodegradable characteristics.
For instance, natural protein fibers, such as keratin, silks, or collagens, are all of interest to researchers
due to their mechanical properties and ability to maintain a low host immune response [157].
Protein-based fiber materials are often used for scaffolds, sutures, wound healing, ligament replacement,
and drug delivery technology. Examples of these applications are summarized in Table 2 at the end of
this section.
4.1. Tissue Engineering and Regenerative Medicine
Tissue engineering has become a major focus in the biomedical engineering community due to the
lack of tissue transplants and host rejection of foreign tissue [158]. To be successful, two components
must be optimized in tissue engineering—the cells and the scaffold. The scaffold is necessary
as it provides the specific architecture and mechanical structure of the desired tissue by closely
recapitulating the natural ECM [158,159].
Protein-based nanofiber membranes can provide an excellent scaffold in tissue engineering due
to the biocompatibility, biodegradability, and tunability of the fibers. The presence of innate cell
adhesion sites and functionality of these constructs also suggests the superiority of protein-based
materials over those made from synthetic polymers when creating scaffolds for tissue engineering.
These scaffolds create a platform for seeding cells in a defined structure, such that it mimics the host
morphology, to catalyze the growth of new specialized tissues. Fibrous membranes also allow for the
development of porous scaffolds, essential for cell migration, gas exchange, diffusion of nutrients,
cell communication, and the elimination of waste, enhancing of the growth of the native ECM and the
proliferation of surrounding cells [159]. Figure 6 maps out the different areas of the human body that
have a need for tissue engineering or regenerative medicine applications.
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Due to its abundance in the ECM, collagen fibers are most commonly used for the creation of
tissue engineering scaffolds. Studies have successfully used these constructs for 3D cell culturing,
vascular regeneration, skin grafts, bone tissue engineering, cartilage repair, nerve regeneration,
spinal cord healing, and corneal defect correction [160–166]. For example, using the electrospinning
method, Ribeiro et al. [167] developed coll gen nanofiber meshes with an average fiber diameter
of 30 nm. D ring spinning, nanohydroxyapatite crystals were also eposited onto the fibers by
simultaneous elect spraying. Nanofibers we e crosslinked with N-ethyl-N′-(3-dimethylaminopr pyl)
carbodiimide/N-hydroxy succinim d , allowing for the cr ation of a scaf ld that c o ely recapitulated
the native ECM of bone tissue and allowed for osteoblast adhesion and proliferation.
Collagen-based nanofibers have also be -f i t ith synthetic polymers to enhance the
mechanical properties of t e scaff l s. For example, as see in Figure 7A,B, Tillman et al. created
an electrospun PCL-collagen scaffold for a rabbit aortoiliac bypass [168]. The scaffold supported
cell growth and was able to withstand normal physiological conditions. Additionally, it supported
adhesion and growth of vascular cells, which was important for nutrient delivery and functionality
of the implanted scaffold. Lastly, it maintained its structural integrity for over one month during
the experiment. Once it was removed, the scaffold displayed biomechanical strength, comparable
to its intended native artery. Ekaputura et al. also used similar collagen-PCL composite nanofibers
encased in a hyaluronic acid hydrogel to promote vascularized bone regeneration through the release
of vascular endothelial growth factor and platelet-derived growth factor [169].
Often, synthetic polymers are incorporated into protein-based fibrous materials to improve
mechanical stability. However, proteins, such as elastin, have been incorporated into synthetic
polymer-based scaffolds to modulate their mechanical properties. Foraida et al. [18] covalently
conjugated elastin onto the surface of electrospun poly-lactic-co-glycolic acid (PLGA) nanofiber
scaffolds through 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide/N-hydroxysulfosuccinimide
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(EDC/NHS) chemistry. While this was found to improve the wettability of the scaffolds, it had
little effect on their elasticity. Therefore, elastin and PLGA were also blended prior to electrospinning
to create elastin-PLGA composite meshes containing fibers with an average diameter of approximately
300 nm. The incorporation of elastin was found to greatly increase the compliance of the fiber
meshes. Compared to PLGA fibers with a Young’s Modulus of 4.29 MPa, the modulus of elastin-PLGA
fibers was 0.59 MPa. As a result, elastin-PLGA nanofibers were able to support apical polarization
and self-organization of epithelial cells, allowing for controllable cell proliferation and a higher
degree of cell-cell contact compared to PLGA fibers. These characteristics better recapitulate the
native arrangement of epithelial cells. As a result, elastin was identified as an integral part of tissue
engineering scaffolds that hope to promote regeneration of epithelial constructs, like salivary glands.
In addition to collagen and elastin, fibrous proteins, such as silk, have been used to create tissue
engineering scaffolds. Figure 7C–E depicts an in vivo rat study reported on by Melke et al. to assess
the capacity of scaffolds made from mulberry B. mori silk and non-mulberry A. mylitta to induce bone
regeneration in a cranial defect model. Since mylitta silk contains the natural RGD (Arg-Gly-Asp)
motif, it allowed for enhanced cell adhesion and proliferation, leading to the regeneration of a higher
bone volume [170]. Kim et al. has also used silk nanofiber meshes to induce bone regeneration.
These meshes were also seeded with stem cells and evaluated after 31 days. They found their
stem cell-seeded scaffolds and meshes were able to guide differentiation and promote new bone
formation [171].Nanomaterials 2018, 8, x FOR PEER REVIEW  14 of 26 
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Figure 7. (A,B) Aortoiliac bypass using a PCL-collagen scaffold; (C–E) Effects of mulberry B. mori silk
and non-mulberry A. mylitta silk on bone regeneration (reproduced with permission from [168,170],
Copyright Elsevier, 2009 (A,B); Elsevier 2016 (C–E)).
Due to its mechanical strength, silk is an ideal protein for tissue regeneration. Recently, Du et al. [87]
also used silk fibroin to produce nanofibrous scaffolds for heart valve tissue engineering, but combined
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the natural polymer with poly(ester-urethane) (PEUU) to improve the fracture resistance of the scaffold.
These scaffolds were created by combining the two polymers in hexafluoroisopropanol and following the
electrospinning technique previously highlighted. Meshes consisting of randomly-orientated fibers with
varying diameters were created. Average diameter and the hydrophilicity of the scaffold were dependent
upon the ratio of silk fibroin to PEUU, both of which decreased with the addition of PEUU. However,
these changes did not significantly affect cell adhesion and proliferation, illustrating that the mechanical
properties of silk materials can be easily optimized through the addition of synthetic polymers without
sacrificing biocompatibility.
Nanofibrous scaffolds made from gelatin have also been developed and may have a promising
future in cartilage tissue regeneration. Agheb et al. [10] developed electrospun gelatin fiber meshes that
were crosslinked before or after synthesis with glutaraldehyde or EDC/NHS chemistry. To increase
the functionality of these scaffolds, the authors also embedded tyrosine and triazole rings since an
increase in aromatic ring content has also been shown to enhance the tensile strength and bioactivity
of materials. Fibers crosslinked after electrospinning exhibited larger diameters, reduced porosity,
greater rigidity, and smaller pore sizes. As a result, those crosslinked before electrospinning sustained
better chondrocyte proliferation and viability in later tests. The incorporation of additional aromatic
rings was also shown to increase chondrocyte viability and allowed them to express their natural
phenotype and morphology, leading the authors to believe that the modified gelatin scaffolds could be
used to promote cartilage regeneration in vivo.
These above studies illustrate that protein-based nanofibers can be used to promote regeneration of
a variety of tissue in nanoscale. In all cases, nanofibers were easily fabricated and modified by chemical
functionalization, crosslinking, or polymer blending showcasing the versatility of such materials.
4.2. Drug Delivery
Nanofiber materials are often used in drug delivery since their high surface-area-to-volume
ratio and porosity allow for high efficiency drug storage and release. Protein-based nanofibers
have particular appeal over their synthetic counterparts since the materials are biodegradable and
biocompatible. They have also been shown to be highly modifiable, allowing researchers to tune the
release of pharmaceuticals.
Due to the biodegradability, flexibility, biocompatibility, anti-microbial properties, and the
anti-oxidant behavior of corn zein protein, it is commonly used to create nanofibers that are used
in drug delivery [19,172]. Figure 8 shows the results of a drug delivery study done with co-axial
electrospun corn zein nanofibers [173]. In coaxial electrospinning, two liquids are spun simultaneously
from one concentric spinneret to create fibers with a core-sheath structure. However, to generate
higher quality fibers with increased smoothness and uniformity, an unspinnable solvent containing no
polymer was used to create the sheath, while corn zein was used to create the core. This unspinnable
solvent, in this case dimethylformamide (DMF), is unable to form nanofibers, but replaces the standard
polymer-air interface usually seen during electrospinning. In this way, an air-solvent-polymer interface
is established, thus mitigating environmental effects on fiber formation. Ferulic acid (FA) was
incorporated into the corn zein-ethanol solution prior to spinning and served as the model drug.
Corn zein nanofibers created through standard electrospinning (without the unspinnable solvent
sheath) were designated F1, while those made with coaxial spinning were designated F2 (Figure 8).
As seen in Figure 8A, FA is released from both types of electrospun corn zein fibers through a standard
Fickian diffusion mechanism. However, F2 fibers exhibited a longer, more controlled release than F1.
This was attributed to the fact that F1 fibers had a flatter, more ribbon-like structure than F2 due to the
coaxial spinning mechanism. F1 fibers also had a more wrinkled appearance than F2. Both of these
characteristics contribute to a higher surface area on the F1 fibers, leading to faster, burst release of FA.
This study illustrates the use of corn zein nanofibers as drug delivery vehicles and also the ability to
optimize fiber fabrication methods to achieve the desired release profiles of drugs.
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Soy protein has also been used to create fiber meshes for applications in drug delivery.
Xu et al. [174] developed soy protein microfibers by dissolving the prot in in an queous urea solution
and extruding it into a sodium sulfate solution. This produced fibers with an average diameter of
45 µm. Model drugs, including diclofenac, 5 fluorouracil (5-Fu), and metformin, were incorporated
into fibers prior to spinning or loaded into fibers through sorption by exposing the dry fibers to
solutions containing drugs at various conditions. Overall, the researchers found that the soy protein
fibers had a high affinity to the model drugs, allowing for efficient sorption loading. This loading
could also be modified by modulating the temperature during fiber exposure. Burst release could also
be limited by lowering the concentration of the loaded drug.
Like those used in tissue engineering, natural and synthetic polymer composite fibers can also be
used for drug release. For example, Lee et al. [175] developed multi-layered PLGA/collagen nanofibers
membranes through electrospinning, that were used to deliver lidocaine and epinephrine over four
weeks. These membranes were then used to deliver the drugs to rabbits with palatal oral wounds
and test groups showed faster hemostasis, as well as recovery of food and water intake, compared to
control groups who received an empty PCL membrane. In place of a model drug, proteins have also
been added to synthetic polymer-based nanofibers and released over time. Zeng et al. [176] prepared
these protein-loaded fibers by electrospinning a solution of poly(vinyl alcohol) and bovine serum
albumin protein (BSA). To control the release of BSA, the fibers were also coated with poly(p-xylylene)
(PPX). This coating was found to slow the release of BSA over 20 days, and successful release of the
model enzyme luciferase was also observed. This demonstrates that proteins can be easily incorporated
into fibers for structural purposes, as well as therapeutic ones.
4.3. Wound Healing
Due to their porosity, gas permeability, and high surface-area-to-volume ratio, fibrous materials
may offer advanced treatment options for burn victims and patients with skin ulcers compared
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to conventional treatment options like hyperbaric oxygen therapy. A successful wound dressing
is one that is able to facilitate epithelial cell migration and regeneration, and this is often best
achieved by creating a warm, moist environment. During healing, it is also important to prevent
the influx of bacteria that can lead to an infection that delays wound healing. To meet these
requirements, protein-based fiber meshes are commonly used for the creation of conventional bandages,
antimicrobial-infused dressings, and advanced tissue engineered skin grafts [177,178].
In an effort to promote wound healing and minimize infection and inflammation
Chouhan et al. [25] recapitulated the physical and biological ECM of dermal tissue by creating
electrospun silk fibroin meshes with varying concentrations of poly(vinyl alcohol) (PVA) for added
mechanical stability. Silk fibroin from the Bombyx mori (PVAABM) silkworm was used, as well as
non-mulberry silk from Antheraea assama (PVAAA) and Philosamia ricini (PVAPR). These meshes were
then functionalized with epidermal growth factor (EGF) and ciprofloxacin HCl antibiotic. All fibers
allowed burst release of EGF, but those containing silk fibroin achieved a greater release over 24 h,
compared to those made solely from PVA. Since non-mulberry silk fibroin contains a naturally occurring
RGD motif, these fiber meshes were also able to support greater cell adhesion and proliferation, as seen
in Figure 9A. Silk fibroin also allowed for greater water retention, allowing for the creation of the moist
environment, crucial in wound regeneration. Due to these characteristics, nanofiber meshes containing
silk fibroin resulted in faster wound closure than meshes containing PVA alone, as seen in Figure 9B,C.
Meshes containing non-mulberry silk fibroin out-performed those containing B. mori silk fibroin with
100% closure being achieved after 14 days, compared to only 80% closure in the latter samples.Nanomaterials 2018, 8, x FOR PEER REVIEW  17 of 26 
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In addition to growth factors and antibiotics, nanoparticles can also be embedded into
protein-based fiber meshes. This is advantageous, since some metal nanoparticles, such as those
made from silver (AgNPs), can have antimicrobial properties. Wang et al. [179] incorporated AgNPs
into keratin-based nanofibers that were blended with polyurethane and fabricated through the
electrospinning process. When used to heal circular wounds in rats, these nanofiber meshes resulted
in 30% wound closure after nine days, compared to only 60% wound closure in a control group
that received conventional sponge dressing. A reduction of TNF-α secretion and inflammatory cell
infiltration was also seen. The incorporation of keratin into poly(hydroxybutylate-cohydroxyvalerate)
(PHBV) nanofiber mats was also shown to accelerate the proliferation of human fibroblast cells,
as demonstrated by Yuan et al. [180].
Table 2. Overview of applications of protein-based nanofibers in medicine.




• PHBV-keratin nanofiber mats
• Dermal wound healing [179]
• Fibroblast cell proliferation [180]
Collagen Electrospinning
• Crosslinked collagen nanofiber meshes
• PCL-collagen nanofiber meshes
• PCL-collagen nanofiber meshes
embedded in hyaluronic acid hydrogel
• PLGA-collagen nanofibers
• Bone tissue regeneration [167]
• Aortoiliac bypass [168]
• Vascularized bone regeneration [169]
• Delivery of lidocaine and epinephrine [175]
Gelatin Electrospinning
• Crosslinked gelatin nanofibers with
embedded tyrosine and triazole rings
• Cartilage regeneration [10]
Silk Fibroin Electrospinning
• Silk fibroin nanofiber meshes
• PEUU-silk fibroin nanofiber mashes
• EGF-functionalized PVA-silk
fibroin nanofibers
• Bone tissue regeneration [171]
• Heart valve regeneration [87]
• Dermal wound healing [25]
Zein Co-axial Electrospinning • Corn zein nanofibers • Delivery of ferulic acid [173]




• Regeneration of epithelial constructs [18]
5. Conclusions
The use of fibrous materials in biomedical research has been growing in popularity due to
their high surface-area-to-volume ratio, tunability, porosity, and mechanical strength. Fibers made
from natural polymers, such as proteins, hold additional promise due to their biodegradability and
biocompatibility. Natural enzymes within the body are able to degrade these proteins to produce
amino acids that pose no risk of toxicity and can be reabsorbed. Proteins, such as silk, collagen,
and keratin, also contain innate cell adhesion motifs. Therefore, when these constructs are used in
tissue engineering or wound healing applications, they can support increased cell migration and
proliferation. The mechanical and physical properties of many protein-based fiber materials can
also be modified by crosslinking or blending an additional polymer, creating a tunable platform.
These characteristics are also highly dependable on the type of the fabrication method used to create
fibers. While electrospinning is currently the most popular technique, other methods, such as wet/dry
jet spinning, dry spinning, centrifugal spinning, solution blowing, self-assembly, phase separation,
and drawing, have been successful. As biomedical research and technology progresses, protein-based
fibers may lead the way in the development of new biomaterials that promote tissue regeneration,
wound healing, and controllable drug delivery.
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7. Tort, S.; Acartürk, F.; Beşikci, A. Evaluation of three-layered doxycycline-collagen loaded nanofiber wound
dressing. Int. J. Pharm. 2017, 529, 642–653. [CrossRef] [PubMed]
8. Zhang, H.; Xia, J.; Pang, X.; Zhao, M.; Wang, B.; Yang, L.; Wan, H.; Wu, J.; Fu, S. Magnetic nanoparticle-loaded
electrospun polymeric nanofibers for tissue engineering. Mater. Sci. Eng. C 2017, 73, 537–543. [CrossRef]
[PubMed]
9. Rijal, N.P.; Adhikari, U.; Khanal, S.; Pai, D.; Sankar, J.; Bhattarai, N. Magnesium oxide-poly(ε-caprolactone)
-chitosan-based composite nanofiber for tissue engineering applications. Mater. Sci. Eng. B 2018, 228, 18–27.
[CrossRef]
10. Agheb, M.; Dinari, M.; Rafienia, M.; Salehi, H. Novel electrospun nanofibers of modified gelatin-tyrosine in
cartilage tissue engineering. Mater. Sci. Eng. C 2017, 71, 240–251. [CrossRef] [PubMed]
11. Unal, B.; Yalcinkaya, E.E.; Demirkol, D.O.; Timur, S. An electrospun nanofiber matrix based on organo-clay
for biosensors: PVA/PAMAM-Montmorillonite. Appl. Surf. Sci. 2018, 444, 542–551. [CrossRef]
12. Guler Gokce, Z.; Akalın, P.; Kok, F.N.; Sarac, A.S. Impedimetric DNA biosensor based on
polyurethane/poly(m-anthranilic acid) nanofibers. Sens. Actuators B Chem. 2018, 254, 719–726. [CrossRef]
13. Migliorini, F.L.; Sanfelice, R.C.; Mercante, L.A.; Andre, R.S.; Mattoso, L.H.C.; Correa, D.S. Urea impedimetric
biosensing using electrospun nanofibers modified with zinc oxide nanoparticles. Appl. Surf. Sci. 2018, 443,
18–23. [CrossRef]
14. Liang, D.; Hsiao, B.S.; Chu, B. Functional electrospun nanofibrous scaffolds for biomedical applications.
Adv. Drug Deliv. Rev. 2007, 59, 1392–1412. [CrossRef] [PubMed]
15. Leung, V.; Ko, F. Biomedical applications of nanofibers. Polym. Adv. Technol. 2011, 22, 350–365. [CrossRef]
16. Bhattarai, N.; Edmondson, D.; Veiseh, O.; Matsen, F.A.; Zhang, M. Electrospun chitosan-based nanofibers
and their cellular compatibility. Biomaterials 2005, 26, 6176–6184. [CrossRef] [PubMed]
17. Elakkiya, T.; Malarvizhi, G.; Rajiv, S.; Natarajan, T.S. Curcumin loaded electrospun Bombyx mori silk
nanofibers for drug delivery. Polym. Int. 2014, 63, 100–105. [CrossRef]
18. Foraida, Z.I.; Kamaldinov, T.; Nelson, D.A.; Larsen, M.; Castracane, J. Elastin-PLGA hybrid electrospun
nanofiber scaffolds for salivary epithelial cell self-organization and polarization. Acta Biomater. 2017, 62,
116–127. [CrossRef] [PubMed]
19. Babitha, S.; Rachita, L.; Karthikeyan, K.; Shoba, E.; Janani, I.; Poornima, B.; Purna Sai, K. Electrospun protein
nanofibers in healthcare: A review. Int. J. Pharm. 2017, 523, 52–90. [CrossRef] [PubMed]
20. Ulery, B.D.; Nair, L.S.; Laurencin, C.T. Biomedical Applications of Biodegradable Polymers. J. Polym. Sci.
Part B Polym. Phys. 2011, 49, 832–864. [CrossRef] [PubMed]
21. Vasconcelos, A.; Freddi, G.; Cavaco-Paulo, A. Biodegradable Materials Based on Silk Fibroin and Keratin.
Biomacromolecules 2008, 9, 1299–1305. [CrossRef] [PubMed]
22. Zhang, H.; Zhou, L.; Zhang, W. Control of Scaffold Degradation in Tissue Engineering: A Review. Tissue Eng.
Part B Rev. 2014, 20, 492–502. [CrossRef] [PubMed]
Nanomaterials 2018, 8, 457 19 of 26
23. Karthikeyan, K.; Guhathakarta, S.; Rajaram, R.; Korrapati, P.S. Electrospun zein/eudragit nanofibers based
dual drug delivery system for the simultaneous delivery of aceclofenac and pantoprazole. Int. J. Pharm.
2012, 438, 117–122. [CrossRef] [PubMed]
24. Vega-Lugo, A.-C.; Lim, L.-T. Controlled release of allyl isothiocyanate using soy protein and poly(lactic acid)
electrospun fibers. Food Res. Int. 2009, 42, 933–940. [CrossRef]
25. Chouhan, D.; Chakraborty, B.; Nandi, S.K.; Mandal, B.B. Role of non-mulberry silk fibroin in deposition
and regulation of extracellular matrix towards accelerated wound healing. Acta Biomater. 2017, 48, 157–174.
[CrossRef] [PubMed]
26. Zhang, X.; Tang, K.; Zheng, X. Electrospinning and Crosslinking of COL/PVA Nanofiber-microsphere
Containing Salicylic Acid for Drug Delivery. J. Bionic Eng. 2016, 13, 143–149. [CrossRef]
27. Hofmann, S.; Wong Po Foo, C.T.; Rossetti, F.; Textor, M.; Vunjak-Novakovic, G.; Kaplan, D.L.; Merkle, H.P.;
Meinel, L. Silk fibroin as an organic polymer for controlled drug delivery. J. Control. Release 2006, 111,
219–227. [CrossRef] [PubMed]
28. Hu, X.; Cebe, P.; Weiss, A.S.; Omenetto, F.; Kaplan, D.L. Protein-based composite materials. Mater. Today
2012, 15, 208–215. [CrossRef]
29. DeFrates, K.; Markiewicz, T.; Callaway, K.; Xue, Y.; Stanton, J.; Salas-de la Cruz, D.; Hu, X. Structure–property
relationships of Thai silk–microcrystalline cellulose biocomposite materials fabricated from ionic liquid.
Int. J. Biol. Macromol. 2017, 104, 919–928. [CrossRef] [PubMed]
30. Song, F.; Tang, D.-L.; Wang, X.-L.; Wang, Y.-Z. Biodegradable Soy Protein Isolate-Based Materials: A Review.
Biomacromolecules 2011, 12, 3369–3380. [CrossRef] [PubMed]
31. Kundu, B.; Rajkhowa, R.; Kundu, S.C.; Wang, X. Silk fibroin biomaterials for tissue regenerations. Adv. Drug
Deliv. Rev. 2013, 65, 457–470. [CrossRef] [PubMed]
32. Davidenko, N.; Schuster, C.F.; Bax, D.V.; Farndale, R.W.; Hamaia, S.; Best, S.M.; Cameron, R.E. Evaluation of
cell binding to collagen and gelatin: A study of the effect of 2D and 3D architecture and surface chemistry.
J. Mater. Sci. Mater. Med. 2016, 27, 148. [CrossRef] [PubMed]
33. Pina, S.; Oliveira, J.M.; Reis, R.L. Natural-Based Nanocomposites for Bone Tissue Engineering and
Regenerative Medicine: A Review. Adv. Mater. 2015, 27, 1143–1169. [CrossRef] [PubMed]
34. Brennan, D.; Jao, D.; Siracusa, M.; Wilkinson, A.; Hu, X.; Beachley, V. Concurrent collection and post-drawing
of individual electrospun polymer nanofibers to enhance macromolecular alignment and mechanical
properties. Polymer 2016, 103, 243–250. [CrossRef]
35. Chomachayi, M.D.; Solouk, A.; Mirzadeh, H. Electrospun silk-based nanofibrous scaffolds: Fiber diameter
and oxygen transfer. Prog. Biomater. 2016, 5, 71–80. [CrossRef] [PubMed]
36. Daamen, W.F.; Veerkamp, J.H.; van Hest, J.C.M.; van Kuppevelt, T.H. Elastin as a biomaterial for tissue
engineering. Biomaterials 2007, 28, 4378–4398. [CrossRef] [PubMed]
37. Wagenseil Jessica, E.; Mecham Robert, P. New insights into elastic fiber assembly. Birth Defects Res. Part C
Embryo Today Rev. 2008, 81, 229–240. [CrossRef] [PubMed]
38. Daamen, W.F.; Nillesen, S.T.; Wismans, R.G.; Reinhardt, D.P.; Hafmans, T.; Veerkamp, J.H.; van Kuppevelt, T.H.
A biomaterial composed of collagen and solubilized elastin enhances angiogenesis and elastic fiber formation
without calcification. Tissue Eng. Part A 2008, 14, 349–360. [CrossRef] [PubMed]
39. Han, J.; Lazarovici, P.; Pomerantz, C.; Chen, X.; Wei, Y.; Lelkes, P.I. Co-Electrospun Blends of PLGA, Gelatin,
and Elastin as Potential Nonthrombogenic Scaffolds for Vascular Tissue Engineering. Biomacromolecules 2011,
12, 399–408. [CrossRef] [PubMed]
40. Annabi, N.; Mithieux, S.M.; Camci-Unal, G.; Dokmeci, M.R.; Weiss, A.S.; Khademhosseini, A. Elastomeric
Recombinant Protein-based Biomaterials. Biochem. Eng. J. 2013, 77, 110–118. [CrossRef] [PubMed]
41. Kim, W.; Chaikof, E.L. Recombinant Elastin-Mimetic Biomaterials: Emerging Applications in Medicine.
Adv. Drug Deliv. Rev. 2010, 62, 1468–1478. [CrossRef] [PubMed]
42. Koria, P.; Yagi, H.; Kitagawa, Y.; Megeed, Z.; Nahmias, Y.; Sheridan, R.; Yarmush, M.L. Self-assembling
elastin-like peptides growth factor chimeric nanoparticles for the treatment of chronic wounds. Proc. Natl.
Acad. Sci. USA 2011, 108, 1034–1039. [CrossRef] [PubMed]
43. MacEwan Sarah, R.; Chilkoti, A. Elastin-like polypeptides: Biomedical applications of tunable biopolymers.
Pept. Sci. 2010, 94, 60–77. [CrossRef] [PubMed]
44. Nuhn, H.; Klok, H.-A. Secondary Structure Formation and LCST Behavior of Short Elastin-Like Peptides.
Biomacromolecules 2008, 9, 2755–2763. [CrossRef] [PubMed]
Nanomaterials 2018, 8, 457 20 of 26
45. Xia, X.-X.; Xu, Q.; Hu, X.; Qin, G.; Kaplan, D.L. Tunable Self-Assembly of Genetically Engineered
Silk–Elastin-like Protein Polymers. Biomacromolecules 2011, 12, 3844–3850. [CrossRef] [PubMed]
46. McClure, M.J.; Sell, S.A.; Simpson, D.G.; Walpoth, B.H.; Bowlin, G.L. A three-layered electrospun matrix
to mimic native arterial architecture using polycaprolactone, elastin, and collagen: A preliminary study.
Acta Biomater. 2010, 6, 2422–2433. [CrossRef] [PubMed]
47. Wise, S.; Byrom, M.; Bannon, P.; Weiss, A.; Ng, M. Electrospun Elastin-based Vascular Grafts. Hear Lung Circ.
2008, 17, S19. [CrossRef]
48. Koens, M.J.W.; Krasznai, A.G.; Hanssen, A.E.J.; Hendriks, T.; Praster, R.; Daamen, W.F.; van der Vliet, J.A.;
van Kuppevelt, T.H. Vascular replacement using a layered elastin-collagen vascular graft in a porcine model:
One week patency versus one month occlusion. Organogenesis 2015, 11, 105–121. [CrossRef] [PubMed]
49. Chattopadhyay, S.; Raines, R.T. Collagen-Based Biomaterials for Wound Healing. Biopolymers 2014, 101,
821–833. [CrossRef] [PubMed]
50. Shoulders, M.D.; Raines, R.T. Collagen Structure and Stability. Annu. Rev. Biochem. 2009, 78, 929–958.
[CrossRef] [PubMed]
51. Tampieri, A.; Celotti, G.; Landi, E.; Sandri, M.; Roveri, N.; Falini, G. Biologically inspired synthesis of bone-like
composite: Self-assembled collagen fibers/hydroxyapatite nanocrystals. J. Biomed. Mater. Res. Part A 2003,
67A, 618–625. [CrossRef] [PubMed]
52. Torculas, M.; Medina, J.; Xue, W.; Hu, X. Protein-based bioelectronics. ACS Biomater. Sci. Eng. 2016, 2,
1211–1223. [CrossRef]
53. Venugopal, J.; Low, S.; Choon, A.T.; Sampath Kumar, T.S.; Ramakrishna, S. Mineralization of osteoblasts with
electrospun collagen/hydroxyapatite nanofibers. J. Mater. Sci. Mater. Med. 2008, 19, 2039–2046. [CrossRef]
[PubMed]
54. Li, W.-J.; Tuli, R.; Okafor, C.; Derfoul, A.; Danielson, K.G.; Hall, D.J.; Tuan, R.S. A three-dimensional
nanofibrous scaffold for cartilage tissue engineering using human mesenchymal stem cells. Biomaterials 2005,
26, 599–609. [CrossRef] [PubMed]
55. Joanne, P.; Kitsara, M.; Boitard, S.-E.; Naemetalla, H.; Vanneaux, V.; Pernot, M.; Larghero, J.; Forest, P.; Chen, Y.;
Menasché, P.; et al. Nanofibrous clinical-grade collagen scaffolds seeded with human cardiomyocytes induces
cardiac remodeling in dilated cardiomyopathy. Biomaterials 2016, 80, 157–168. [CrossRef] [PubMed]
56. Xu, C.Y.; Inai, R.; Kotaki, M.; Ramakrishna, S. Aligned biodegradable nanofibrous structure: A potential
scaffold for blood vessel engineering. Biomaterials 2004, 25, 877–886. [CrossRef]
57. Gentleman, E.; Lay, A.N.; Dickerson, D.A.; Nauman, E.A.; Livesay, G.A.; Dee, K.C. Mechanical
characterization of collagen fibers and scaffolds for tissue engineering. Biomaterials 2003, 24, 3805–3813.
[CrossRef]
58. Caruso Andrea, B.; Dunn Michael, G. Functional evaluation of collagen fiber scaffolds for ACL reconstruction:
Cyclic loading in proteolytic enzyme solutions. J. Biomed. Mater. Res. Part A 2004, 69A, 164–171. [CrossRef]
[PubMed]
59. Kumbar, S.G.; Nukavarapu, S.P.; James, R.; Nair, L.S.; Laurencin, C.T. Electrospun poly(lactic acid-co-glycolic
acid) scaffolds for skin tissue engineering. Biomaterials 2008, 29, 4100–4107. [CrossRef] [PubMed]
60. Powell, H.M.; Boyce, S.T. Engineered Human Skin Fabricated Using Electrospun Collagen–PCL Blends:
Morphogenesis and Mechanical Properties. Tissue Eng. Part A 2009, 15, 2177–2187. [CrossRef] [PubMed]
61. Choi, J.S.; Lee, S.J.; Christ, G.J.; Atala, A.; Yoo, J.J. The influence of electrospun aligned
poly(
Nanomaterials 2018, 8, x FOR PEER REVIEW  21 of 26 
 
48. Koens, M.J.W.; Krasznai, A.G.; Hanssen, A.E.J.; Hendriks, T.; Praster, R.; Daamen, W.F.; van der Vliet, J.A.; 
van Kuppevelt, T.H. Vascular replacement using a layered elastin-collagen vascular graft in a porcine 
model: One week patency versus one month occlusion. Organogenesis 2015, 11, 105–121. 
49. Chattopadhyay, S.; Raines, R.T. Collagen-Based Biomaterials for Wound Healing. Biopolymers 2014, 101, 
821–833. 
50. Shoulders, M.D.; Raines, R.T. Collagen Structure and Stability. Annu. Rev. Biochem. 2009, 78, 929–958. 
51. Tampieri, A.; Celotti, G.; Landi, E.; Sandri, M.; Roveri, N.; Falini, G. Biologically inspired synthesis of bone-
like composite: Self-assembled collagen fibers/hydroxyapatite nanocrystals. J. Biomed. Mater. Res. Part A 
2003, 67A, 618–625. 
52. Torculas, M.; Medina, J.; Xue, W.; Hu, X. Protein-based bioelectronics. ACS Biomater. Sci. Eng. 2016, 2, 1211–
1223. 
53. Venugopal, J.; Low, S.; Choon, A.T.; Sampath Kumar, T.S.; Ramakrishna, S. Mineralization of osteoblasts 
with electrospun collagen/hydroxyapatite nanofibers. J. Mater. Sci. Mater. Med. 2008, 19, 2039–2046. 
54. Li, W.-J.; Tuli, R.; Okafor, C.; Derfoul, A.; Danielson, K.G.; Hall, D.J.; Tuan, R.S. A three-dimensional 
nanofibrous scaffold for cartilage tissue engineering using human mesenchymal stem cells. Biomaterials 
2005, 26, 599–609. 
55. Joanne, P.; Kitsara, M.; Boitard, S.-E.; Naemetalla, H.; Vanneaux, V.; Pernot, M.; Larghero, J.; Forest, P.; 
Chen, Y.; Menasché, P.; et al. Nanofibrous clinical-grade collagen scaffolds seeded with human 
cardiomyocytes induces cardiac remodeling in dilated cardiomyopathy. Biomaterials 2016, 80, 157–168. 
56. Xu, C.Y.; Inai, R.; Kotaki, M.; Ramakrishna, S. Aligned biodegradable nanofibrous structure: A potential 
scaffold for blood vessel engineering. Biomaterials 2004, 25, 877–886. 
57. Gentleman, E.; Lay, A.N.; Dickerson, D.A.; Nauman, E.A.; Livesay, G.A.; Dee, K.C. Mechanical 
characterization of collagen fibers and scaffolds for tissue engineering. Biomaterials 2003, 24, 3805–3813. 
58. Caruso Andrea, B.; Dunn Michael, G. Functional evaluation of collagen fiber scaffolds for ACL 
reconstruction: Cyclic loading in proteolytic enzyme solutions. J. Biomed. Mater. Res. Part A 2004, 69A, 164–
171. 
59. Kumbar, S.G.; Nukavarapu, S.P.; James, R.; Nair, L.S.; Laurencin, C.T. Electrospun poly(lactic acid-co-
glycolic acid) scaffolds for skin tissue engineering. Biomaterials 2008, 29, 4100–4107. 
60. Powell, H.M.; Boyce, S.T. Engineered Human Skin Fabricated Using Electrospun Collagen–PCL Blends: 
Morphogenesis and Mechanical Properties. Tissue Eng. Part A 2009, 15, 2177–2187. 
61. Choi, J.S.; Lee, S.J.; Christ, G.J.; Atala, A.; Yoo, J.J. The influence of electrospun aligned p l ɛ-
caprolactone)/collagen nanofiber meshes on the formation of self-aligned skeletal muscle myotubes. 
Biomaterials 2008, 29, 2899–2906. 
62. Timnak, A.; Yousefi Gharebaghi, F.; Pajoum Shariati, R.; Bahrami, S.H.; Javadian, S.; Hojjati Emami, S.; 
Shokrgozar, M.A. Fabrication of nano-structured electrospun collagen scaffold intended for nerve tissue 
engineering. J. Mater. Sci. Mater. Med. 2011, 22, 1555–1567. 
63. Bini, T.B.; Shujun, G.; Ter Chyan, T.; Shu, W.; Aymeric, L.; Lim Ben, H.; Ramakrishna, S. Electrospun poly(L-
lactide-co-glycolide) biodegradable polymer nanofibre tubes for peripheral nerve regeneration. 
Nanotechnology 2004, 15, 1459. 
64. Hu, Y.; Dan, W.; Xiong, S.; Kang, Y.; Dhinakar, A.; Wu, J.; Gu, Z. Development of collagen/polydopamine 
complexed matrix as mechanically enhanced and highly biocompatible semi-natural tissue engineering 
scaffold. Acta Biomater. 2017, 47, 135–148. 
65. Luo, X.; Guo, Z.; He, P.; Chen, T.; Li, L.; Ding, S.; Li, H. Study on structure, mechanical property and cell 
cytocompatibility of electrospun collagen nanofibers crosslinked by common agents. Int. J. Biol. Macromol. 
2018, 113, 476–486. 
66. Zhang, Y.; Ouyang, H.; Lim Chwee, T.; Ramakrishna, S.; Huang, Z.M. Electrospinning of gelatin fibers and 
gelatin/PCL composite fibrous scaffolds. J. Biomed. Mater. Res. Part B Appl. Biomater. 2004, 72B, 156–165. 
67. Chen, T.; Embree, H.D.; Brown, E.M.; Taylor, M.M.; Payne, G.F. Enzyme-catalyzed gel formation of gelatin 
and chitosan: Potential for in situ applications. Biomaterials 2003, 24, 2831–2841. 
68. Bigi, A.; Cojazzi, G.; Panzavolta, S.; Rubini, K.; Roveri, N. Mechanical and thermal properties of gelatin 
films at different degrees of glutaraldehyde crosslinking. Biomaterials 2001, 22, 763–768. 
69. DeFrates, K.; Markiewicz, T.; Gallo, P.; Rack, A.; Weyhmiller, A.; Jarmusik, B.; Hu, X. Protein polymer-
based nanoparticles: fabrication and medical applications. Int. J. Mol. Sci. 2018, 19, 1717. 
caprolactone)/collagen nanofiber meshes on the formation of self-aligned skeletal muscle myotubes.
Biomaterials 2008, 29, 2899–2906. [CrossRef] [PubMed]
62. Timnak, A.; Yousefi Gharebaghi, F.; Pajoum Shariati, R.; Bahrami, S.H.; Javadian, S.; Hojjati Emami, S.;
Shokrgozar, M.A. Fabrication of nano-structured electrospun collagen scaffold intended for nerve tissue
engineering. J. Mater. Sci. Mater. Med. 2011, 22, 1555–1567. [CrossRef] [PubMed]
63. Bini, T.B.; Shujun, G.; Ter Chyan, T.; Shu, W.; Aymeric, L.; Lim Ben, H.; Ramakrishna, S. Electrospun
poly(L-lactide-co-glycolide) biodegradable polymer nanofibre tubes for peripheral nerve regeneration.
Nanotechnology 2004, 15, 1459. [CrossRef]
64. Hu, Y.; Dan, W.; Xiong, S.; Kang, Y.; Dhinakar, A.; Wu, J.; Gu, Z. Development of collagen/polydopamine
complexed matrix as mechanically enhanced and highly biocompatible semi-natural tissue engineering
scaffold. Acta Biomater. 2017, 47, 135–148. [CrossRef] [PubMed]
Nanomaterials 2018, 8, 457 21 of 26
65. Luo, X.; Guo, Z.; He, P.; Chen, T.; Li, L.; Ding, S.; Li, H. Study on structure, mechanical property and cell
cytocompatibility of electrospun collagen nanofibers crosslinked by common agents. Int. J. Biol. Macromol.
2018, 113, 476–486. [CrossRef] [PubMed]
66. Zhang, Y.; Ouyang, H.; Lim Chwee, T.; Ramakrishna, S.; Huang, Z.M. Electrospinning of gelatin fibers and
gelatin/PCL composite fibrous scaffolds. J. Biomed. Mater. Res. Part B Appl. Biomater. 2004, 72B, 156–165.
[CrossRef] [PubMed]
67. Chen, T.; Embree, H.D.; Brown, E.M.; Taylor, M.M.; Payne, G.F. Enzyme-catalyzed gel formation of gelatin
and chitosan: Potential for in situ applications. Biomaterials 2003, 24, 2831–2841. [CrossRef]
68. Bigi, A.; Cojazzi, G.; Panzavolta, S.; Rubini, K.; Roveri, N. Mechanical and thermal properties of gelatin films
at different degrees of glutaraldehyde crosslinking. Biomaterials 2001, 22, 763–768. [CrossRef]
69. DeFrates, K.; Markiewicz, T.; Gallo, P.; Rack, A.; Weyhmiller, A.; Jarmusik, B.; Hu, X. Protein polymer-based
nanoparticles: fabrication and medical applications. Int. J. Mol. Sci. 2018, 19, 1717. [CrossRef] [PubMed]
70. Rose, B.J.; Pacelli, S.; Haj, J.A.; Dua, S.H.; Hopkinson, A.; White, J.L.; Rose, R.F. Gelatin-Based Materials in
Ocular Tissue Engineering. Materials 2014, 7, 3106–3135. [CrossRef] [PubMed]
71. Baradaran-Rafii, A.; Biazar, E.; Heidari-Keshel, S. Cellular Response of Limbal Stem Cells on PHBV/Gelatin
Nanofibrous Scaffold for Ocular Epithelial Regeneration. Int. J. Polym. Mater. Polym. Biomater. 2015, 64,
879–887. [CrossRef]
72. Ji, W.; Yang, F.; Ma, J.; Bouma, M.J.; Boerman, O.C.; Chen, Z.; van den Beucken, J.J.J.P.; Jansen, J.A.
Incorporation of stromal cell-derived factor-1α in PCL/gelatin electrospun membranes for guided bone
regeneration. Biomaterials 2013, 34, 735–745. [CrossRef] [PubMed]
73. Liu, Y.; Lu, Y.; Tian, X.; Cui, G.; Zhao, Y.; Yang, Q.; Yu, S.; Xing, G.; Zhang, B. Segmental bone regeneration
using an rhBMP-2-loaded gelatin/nanohydroxyapatite/fibrin scaffold in a rabbit model. Biomaterials 2009,
30, 6276–6285. [CrossRef] [PubMed]
74. Ravichandran, R.; Venugopal, J.R.; Sundarrajan, S.; Mukherjee, S.; Ramakrishna, S. Poly(Glycerol
Sebacate)/Gelatin Core/Shell Fibrous Structure for Regeneration of Myocardial Infarction. Tissue Eng.
Part A 2011, 17, 1363–1373. [CrossRef] [PubMed]
75. Kai, D.; Prabhakaran Molamma, P.; Jin, G.; Ramakrishna, S. Guided orientation of cardiomyocytes on
electrospun aligned nanofibers for cardiac tissue engineering. J. Biomed. Mater. Res. Part B Appl. Biomater.
2011, 98B, 379–386. [CrossRef] [PubMed]
76. Ghasemi-Mobarakeh, L.; Prabhakaran, M.P.; Morshed, M.; Nasr-Esfahani, M.-H.; Ramakrishna, S.
Electrospun poly(
Nanomaterials 2018, 8, x FOR PEER REVIEW  21 of 26 
 
48. Koens, M.J.W.; Krasznai, A.G.; Hanssen, A.E.J.; Hendriks, T.; Praster, R.; Daamen, W.F.; van der Vliet, J.A.; 
van Kuppevelt, T.H. Vascular replacement using a layered elastin-collagen vascular graft in a porcine 
model: One week patency versus one month occlusion. Organogenesis 2015, 11, 105–121. 
49. Chattopadhyay, S.; Raines, R.T. Collagen-Based Biomaterials for Wound Healing. Biopolymers 2014, 101, 
821–833. 
50. Shoulders, M.D.; Raines, R.T. Collagen Structure and Stability. Annu. Rev. Biochem. 2009, 78, 929–958. 
51. Tampieri, A.; Celotti, G.; Landi, E.; Sandri, M.; Roveri, N.; Falini, G. Biologically inspired synthesis of bone-
like composite: Self-assembled collagen fibers/hydroxyapatite nanocrystals. J. Biomed. Mater. Res. Part A 
2003, 67A, 618–625. 
52. Torculas, M.; Medina, J.; Xue, W.; Hu, X. Protein-based bioelectronics. ACS Biomater. Sci. Eng. 2016, 2, 1211–
1223. 
53. Venugopal, J.; Low, S.; Choon, A.T.; Sampath Kumar, T.S.; Ramakrishna, S. Mineralization of osteoblasts 
with electrospun collagen/hydroxyapatite nanofibers. J. Mater. Sci. Mater. Med. 2008, 19, 2039–2046  
54. Li, W.-J.; Tuli, R.; Okafor, C.; Derfoul, A.; Danielson, K.G.; Hall, D.J.; Tuan, R.S. A three-dimensional 
nanofibrous scaffold for cartilage tissue engineering using human mesenchymal stem cells. Biomaterials 
2005, 26, 599–609. 
55. Joanne, P.; Kitsara, M.; Boitard, S.-E.; Naemetalla, H.; Vanneaux, V.; Pernot, M.; Larghero, J.; Forest, P.; 
Chen, Y.; Menasché, P.; et al. Nanofibrous clinical-grade collagen scaffolds seeded with human 
cardiomyocytes induces cardiac remodeling in dilated cardiomyopathy. Biomaterials 2016, 80, 157–168. 
56. Xu, C.Y.; Inai, R.; Kotaki, M.; Ramakrishna, S. Aligned biodegradable nanofibrous structure: A potential 
scaffold for blood vessel engineering. Biomaterials 2004, 25, 877–886. 
57. Gentleman, E.; Lay, A.N.; Dickerson, D.A.; Nauman, E.A.; Livesay, G.A.; Dee, K.C. Mechanical 
characterization of collagen fibers and scaffolds for tissue engineering. Biomaterials 2003, 24, 3805–3813. 
58. Caruso Andrea, B.; Dunn Michael, G. Functional evaluation of collagen fiber scaffolds for ACL 
reconstruction: Cyclic loading in proteolytic enzyme solutions. J. Biomed. Mater. Res. Part A 2004, 69A, 164–
171. 
59. Kumbar, S.G.; Nukavarapu, S.P.; James, R.; Nair, L.S.; Laurencin, C.T. Electrospun poly(lactic acid-co-
glycolic acid) scaffolds for skin tissue engineering. Biomaterials 2008, 29, 4100–4107. 
60. Powell, H.M.; Boyce, S.T. Engineered Human Skin Fabricated Using Electrospun Collagen–PCL Blends: 
Morphogenesis and Mechanical Properties. Tissue Eng. Part A 2009, 15, 2177–2187. 
61. Choi, J.S.; Lee, S.J.; Christ, G.J.; Atala, A.; Yoo, J.J. The influence of electrospun aligned ɛ-
caprolactone)/collagen nanofiber meshes on the formation of self-aligned skeletal muscle myotubes. 
Biomaterials 2008, 29, 2899–2906. 
62. Timnak, A.; Yousefi Gharebaghi, F.; Pajoum Shariati, R.; Bahrami, S.H.; Javadian, S.; Hojjati Emami, S.; 
Shokrgozar, M.A. Fabrication of nano-structured electrospun collagen scaffold intended for nerve tissue 
engineering. J. Mater. Sci. Mater. Med. 2011, 22, 1555–1567. 
63. Bini, T.B.; Shujun, G.; Ter Chyan, T.; Shu, W.; Aymeric, L.; Lim Ben, H.; Ramakrishna, S. Electrospun poly(L-
lactide-co-glycolide) biodegradable polymer nanofibre tubes for peripheral nerve regeneration. 
Nanotechnology 2004, 15, 1459. 
64. Hu, Y.; Dan, W.; Xiong, S.; Kang, Y.; Dhinakar, A.; Wu, J.; Gu, Z. Development of collagen/polydopamine 
complexed matrix as mechanically enhanced and highly biocompatible semi-natural tissue engineering 
scaffold. Acta Biomater. 2017, 47, 135–148. 
65. Luo, X.; Guo, Z.; He, P.; Chen, T.; Li, L.; Ding, S.; Li, H. Study on structure, mechanical property and cell 
cytocompatibility of electrospun collagen nanofibers crosslinked by common agents. Int. J. Biol. Macromol. 
2018, 113, 476–486. 
66. Zhang, Y.; Ouyang, H.; Lim Chwee, T.; Ramakrishna, S.; Huang, Z.M. Electrospinning of gelatin fibers and 
gelatin/PCL composite fibrous scaffolds. J. Biomed. Mater. Res. Part B Appl. Biomater. 2004, 72B, 156–165. 
67. Chen, T.; Embree, H.D.; Brown, E.M.; Taylor, M.M.; Payne, G.F. Enzyme-catalyzed gel formation of gelatin 
and chitosan: Potential for in situ applications. Biomaterials 2003, 24, 2831–2841. 
68. Bigi, A.; Cojazzi, G.; Panzavolta, S.; Rubini, K.; Roveri, N. Mechanical and thermal properties of gelatin 
films at different degrees of glutaraldehyde crosslinking. Biomaterials 2001, 22, 763–768. 
69. DeFrates, K.; Markiewicz, T.; Gallo, P.; Rack, A.; Weyhmiller, A.; Jarmusik, B.; Hu, X. Protein polymer-
based nanoparticles: fabrication and medical applications. Int. J. Mol. Sci. 2018, 19, 1717. 
caprolactone)/gelatin nanofibrous scaffolds for nerve tissue engineering. Biomaterials
2008, 29, 4532–4539 [CrossRef] [PubMed]
77. Chen, Y.-S.; Chang, J.-Y.; Cheng, C.-Y.; Tsai, F.-J.; Yao, C.-H.; Liu, B.-S. An in vivo evaluation of a biodegradable
genipin-cross-linked gelatin peripheral nerve guide conduit material. Biomaterials 2005, 26, 3911–3918.
[CrossRef] [PubMed]
78. Chong, E.J.; Phan, T.T.; Lim, I.J.; Zhang, Y.Z.; Bay, B.H.; Ramakrishna, S.; Lim, C.T. Evaluation of electrospun
PCL/gelatin nanofibrous scaffold for wound healing and layered dermal reconstitution. Acta Biomater. 2007,
3, 321–330. [CrossRef] [PubMed]
79. Jao, D.; Mou, X.; Hu, X. Tissue Regeneration: A Silk Road. J. Funct. Biomater. 2016, 7, 22. [CrossRef] [PubMed]
80. Lefèvre, T.; Rousseau, M.-E.; Pézolet, M. Protein Secondary Structure and Orientation in Silk as Revealed by
Raman Spectromicroscopy. Biophys. J. 2007, 92, 2885–2895. [CrossRef] [PubMed]
81. Vepari, C.; Kapla , D.L. Silk as a biomaterial. Prog. Polym. Sci. 2007, 32, 991–1007. [CrossRef] [PubMed]
82. Najjar, R.; Luo, Y.; Jao, D.; Brennan, D.; Xue, Y.; Beachley, V.; Hu, X.; Xue, W. Biocompatible silk/polymer
energy harvesters using stretched poly (vinylidene fluoride-co-hexafluoropropylene) (PVDF-HFP) nanofibers.
Polymers 2017, 9, 479. [CrossRef]
83. Meinel, L.; Karageorgiou, V.; Hofmann, S.; Fajardo, R.; Snyder, B.; Li, C.; Zichner, L.; Langer, R.;
Vunjak-Novakovic, G.; Kaplan, D.L. Engineering bone-like tissue in vitro using human bone marrow stem
cells and silk scaffolds. J. Biomed. Mater. Res. Part A 2004, 71A, 25–34. [CrossRef] [PubMed]
84. Sommer, M.R.; Vetsch, J.R.; Leemann, J.; Müller, R.; Studart, A.R.; Hofmann, S. Silk fibroin scaffolds with
inverse opal structure for bone tissue engineering. J. Biomed. Mater. Res. Part B Appl. Biomater. 2017, 105,
2074–2084. [CrossRef] [PubMed]
Nanomaterials 2018, 8, 457 22 of 26
85. Aliramaji, S.; Zamanian, A.; Mozafari, M. Super-paramagnetic responsive silk fibroin/chitosan/magnetite
scaffolds with tunable pore structures for bone tissue engineering applications. Mater. Sci. Eng. C 2017, 70,
736–744. [CrossRef] [PubMed]
86. Vishwanath, V.; Pramanik, K.; Biswas, A. Development of a novel glucosamine/silk fibroin–chitosan blend
porous scaffold for cartilage tissue engineering applications. Iran. Polym. J. 2017, 26, 11–19. [CrossRef]
87. Du, J.; Zhu, T.; Yu, H.; Zhu, J.; Sun, C.; Wang, J.; Chen, S.; Wang, J.; Guo, X. Potential applications of
three-dimensional structure of silk fibroin/poly(ester-urethane) urea nanofibrous scaffold in heart valve
tissue engineering. Appl. Surf. Sci. 2018, 447, 269–278. [CrossRef]
88. Rao, J.; Cheng, Y.; Liu, Y.; Ye, Z.; Zhan, B.; Quan, D.; Xu, Y. A multi-walled silk fibroin/silk sericin nerve
conduit coated with poly(lactic-co-glycolic acid) sheath for peripheral nerve regeneration. Mater. Sci. Eng. C
2017, 73, 319–332. [CrossRef] [PubMed]
89. Zhang, W.; Chen, L.; Chen, J.; Wang, L.; Gui, X.; Ran, J.; Xu, G.; Zhao, H.; Zeng, M.; Ji, J.; et al. Silk Fibroin
Biomaterial Shows Safe and Effective Wound Healing in Animal Models and a Randomized Controlled
Clinical Trial. Adv. Healthc. Mater. 2017, 6, 1700121. [CrossRef] [PubMed]
90. Min, B.-M.; Lee, G.; Kim, S.H.; Nam, Y.S.; Lee, T.S.; Park, W.H. Electrospinning of silk fibroin nanofibers and
its effect on the adhesion and spreading of normal human keratinocytes and fibroblasts in vitro. Biomaterials
2004, 25, 1289–1297. [CrossRef] [PubMed]
91. Hafner, K.; Montag, D.; Maeser, H.; Peng, C.; Marcotte, W.R.; Dean, D.; Kennedy, M.S. Evaluating adhesion
and alignment of dental pulp stem cells to a spider silk substrate for tissue engineering applications.
Mater. Sci. Eng. C 2017, 81, 104–112. [CrossRef] [PubMed]
92. Hou, J.; Xie, Y.; Ji, A.; Cao, A.; Fang, Y.; Shi, E. Carbon-Nanotube-Wrapped Spider Silks for Directed
Cardiomyocyte Growth and Electrophysiological Detection. ACS Appl. Mater. Interfaces 2018, 10, 6793–6798.
[CrossRef] [PubMed]
93. Rouse, J.G.; Van Dyke, M.E. A Review of Keratin-Based Biomaterials for Biomedical Applications. Materials
2010, 3, 999–1014. [CrossRef]
94. MacKinnon, P.J.; Powell, B.C.; Rogers, G.E. Structure and expression of genes for a class of cysteine-rich
proteins of the cuticle layers of differentiating wool and hair follicles. J. Cell Biol. 1990, 111, 2587–2600.
[CrossRef] [PubMed]
95. Zhu, H.; Li, R.; Wu, X.; Chen, K.; Che, J. Controllable fabrication and characterization of hydrophilic
PCL/wool keratin nanonets by electronetting. Eur. Polym. J. 2017, 86, 154–161. [CrossRef]
96. Esparza, Y.; Ullah, A.; Boluk, Y.; Wu, J. Preparation and characterization of thermally crosslinked poly(vinyl
alcohol)/feather keratin nanofiber scaffolds. Mater. Des. 2017, 133, 1–9. [CrossRef]
97. Arslan, Y.E.; Sezgin Arslan, T.; Derkus, B.; Emregul, E.; Emregul, K.C. Fabrication of human hair
keratin/jellyfish collagen/eggshell-derived hydroxyapatite osteoinductive biocomposite scaffolds for bone
tissue engineering: From waste to regenerative medicine products. Colloids Surf. B Biointerfaces 2017, 154,
160–170. [CrossRef] [PubMed]
98. Xu, S.; Sang, L.; Zhang, Y.; Wang, X.; Li, X. Biological evaluation of human hair keratin scaffolds for skin
wound repair and regeneration. Mater. Sci. Eng. C 2013, 33, 648–655. [CrossRef] [PubMed]
99. Xu, H.; Cai, S.; Xu, L.; Yang, Y. Water-Stable Three-Dimensional Ultrafine Fibrous Scaffolds from Keratin for
Cartilage Tissue Engineering. Langmuir 2014, 30, 8461–8470. [CrossRef] [PubMed]
100. Hualin, Z.; Jinsong, L. Electrospun poly(lactic-co-glycolic acid)/wool keratin fibrous composite scaffolds
potential for bone tissue engineering applications. J. Bioact. Compat. Polym. 2013, 28, 141–153.
101. Wang, J.Y.; Fujimoto, K.; Miyazawa, T.; Endo, Y. Antioxidative mechanism of maize zein in powder model
systems against methyl linoleate: Effect of water activity and coexistence of antioxidants. J. Agric. Food Chem.
1991, 39, 351–355. [CrossRef]
102. Dong, J.; Sun, Q.; Wang, J.-Y. Basic study of corn protein, zein, as a biomaterial in tissue engineering, surface
morphology and biocompatibility. Biomaterials 2004, 25, 4691–4697. [CrossRef] [PubMed]
103. Wang, H.-J.; Di, L.; Ren, Q.-S.; Wang, J.-Y. Applications and Degradation of Proteins Used as Tissue
Engineering Materials. Materials 2009, 2, 613–635. [CrossRef]
104. Demir, M.; Ramos-Rivera, L.; Silva, R.; Nazhat, S.N.; Boccaccini, A.R. Zein-based composites in biomedical
applications. J. Biomed. Mater. Res. Part A 2017, 105, 1656–1665. [CrossRef] [PubMed]
Nanomaterials 2018, 8, 457 23 of 26
105. Yang, F.; Miao, Y.; Wang, Y.; Zhang, L.-M.; Lin, X. Electrospun Zein/Gelatin Scaffold-Enhanced Cell
Attachment and Growth of Human Periodontal Ligament Stem Cells. Materials 2017, 10, 1168. [CrossRef]
[PubMed]
106. Vogt, L.; Liverani, L.; Roether, J.; Boccaccini, A. Electrospun Zein Fibers Incorporating Poly(glycerol sebacate)
for Soft Tissue Engineering. Nanomaterials 2018, 8, 150. [CrossRef] [PubMed]
107. Jiang, Q.; Reddy, N.; Yang, Y. Cytocompatible cross-linking of electrospun zein fibers for the development of
water-stable tissue engineering scaffolds. Acta Biomater. 2010, 6, 4042–4051. [CrossRef] [PubMed]
108. Paliwal, R.; Palakurthi, S. Zein in controlled drug delivery and tissue engineering. J. Control. Release Off. J.
Control. Release Soc. 2014, 189, 108–122. [CrossRef] [PubMed]
109. Bouman, J.; Belton, P.; Venema, P.; van der Linden, E.; de Vries, R.; Qi, S. Controlled Release from Zein
Matrices: Interplay of Drug Hydrophobicity and pH. Pharm. Res. 2016, 33, 673–685. [CrossRef] [PubMed]
110. Labib, G. Overview on zein protein: A promising pharmaceutical excipient in drug delivery systems and
tissue engineering. Expert Opin. Drug Deliv. 2018, 15, 65–75. [CrossRef] [PubMed]
111. Tansaz, S.; Boccaccini, A.R. Biomedical applications of soy protein: A brief overview. J. Biomed. Mater. Res.
Part A 2016, 104, 553–569. [CrossRef] [PubMed]
112. Li, S.; Donner, E.; Xiao, H.; Thompson, M.; Zhang, Y.; Rempel, C.; Liu, Q. Preparation and characterization of
soy protein films with a durable water resistance-adjustable and antimicrobial surface. Mater. Sci. Eng. C
2016, 69, 947–955. [CrossRef] [PubMed]
113. Maruthi, Y.; Sudhakar, H.; Rao, U.S.; Babu, P.K.; Rao, K.C.; Subha, M.C.S. Blend Membranes of Sodium
alginate and Soya protein for Pervaporation Dehydration of Isopropanol. Adv. Polym. Sci. Technol. 2014, 4,
12–21.
114. Tansaz, S.; Liverani, L.; Vester, L.; Boccaccini, A.R. Soy protein meets bioactive glass: Electrospun composite
fibers for tissue engineering applications. Mater. Lett. 2017, 199, 143–146. [CrossRef]
115. Ahn, S.; Chantre, C.O.; Gannon, A.R.; Lind, J.U.; Campbell, P.H.; Grevesse, T.; O’Connor, B.B.; Parker, K.K.
Soy Protein/Cellulose Nanofiber Scaffolds Mimicking Skin Extracellular Matrix for Enhanced Wound
Healing. Adv. Healthc. Mater. 2018, 7, 1701175. [CrossRef] [PubMed]
116. Xu, H.; Cai, S.; Sellers, A.; Yang, Y. Intrinsically water-stable electrospun three-dimensional ultrafine fibrous
soy protein scaffolds for soft tissue engineering using adipose derived mesenchymal stem cells. RSC Adv.
2014, 4, 15451–15457. [CrossRef]
117. Silva, S.S.; Goodfellow, B.J.; Benesch, J.; Rocha, J.; Mano, J.F.; Reis, R.L. Morphology and miscibility of
chitosan/soy protein blended membranes. Carbohydr. Polym. 2007, 70, 25–31. [CrossRef]
118. Beachley, V.; Wen, X. Effect of electrospinning parameters on the nanofiber diameter and length. Mater. Sci.
Eng. C Mater. Biol. Appl. 2009, 29, 663–668. [CrossRef] [PubMed]
119. Charernsriwilaiwat, N.; Opanasopit, P.; Rojanarata, T.; Ngawhirunpat, T.; Supaphol, P. Preparation
and characterization of chitosan-hydroxybenzotriazole/polyvinyl alcohol blend nanofibers by the
electrospinning technique. Carbohydr. Polym. 2010, 81, 675–680. [CrossRef]
120. Pakravan, M.; Heuzey, M.-C.; Ajji, A. A fundamental study of chitosan/PEO electrospinning. Polymer 2011,
52, 4813–4824. [CrossRef]
121. Tan, S.H.; Inai, R.; Kotaki, M.; Ramakrishna, S. Systematic parameter study for ultra-fine fiber fabrication via
electrospinning process. Polymer 2005, 46, 6128–6134. [CrossRef]
122. Arafat, M.T.; Tronci, G.; Yin, J.; Wood, D.J.; Russell, S.J. Biomimetic wet-stable fibres via wet spinning and
diacid-based crosslinking of collagen triple helices. Polymer 2015, 77, 102–112. [CrossRef]
123. Yan, J.; Zhou, G.; Knight, D.P.; Shao, Z.; Chen, X. Wet-Spinning of Regenerated Silk Fiber from Aqueous Silk
Fibroin Solution: Discussion of Spinning Parameters. Biomacromolecules 2010, 11, 1–5. [CrossRef] [PubMed]
124. Plaza, G.R.; Corsini, P.; Marsano, E.; Pérez-Rigueiro, J.; Elices, M.; Riekel, C.; Vendrely, C.; Guinea, G.V.
Correlation between processing conditions, microstructure and mechanical behavior in regenerated silkworm
silk fibers. J. Polym. Sci. Part B Polym. Phys. 2012, 50, 455–465. [CrossRef]
125. Um, I.C.; Ki, C.S.; Kweon, H.; Lee, K.G.; Ihm, D.W.; Park, Y.H. Wet spinning of silk polymer. II. Effect of
drawing on the structural characteristics and properties of filament. Int. J. Biol. Macromol. 2004, 34, 107–119.
[CrossRef] [PubMed]
126. Wei, W.; Zhang, Y.; Zhao, Y.; Luo, J.; Shao, H.; Hu, X. Bio-inspired capillary dry spinning of regenerated silk
fibroin aqueous solution. Mater. Sci. Eng. C 2011, 31, 1602–1608. [CrossRef]
Nanomaterials 2018, 8, 457 24 of 26
127. Xie, J.; Wang, C.H. Electrospun micro and nanofibers for sustained delivery of paclitaxel to treat C6 glioma
in vitro. Pharm. Res. 2006, 23, 1817. [CrossRef] [PubMed]
128. Loordhuswamy, A.M.; Krishnaswamy, V.R.; Korrapati, P.S.; Thinakaran, S.; Rengaswami, G.D. Fabrication of
highly aligned fibrous scaffolds for tissue regeneration by centrifugal spinning technology. Mater. Sci. Eng.
C Mater. Biol. Appl. 2014, 42, 799–807. [CrossRef] [PubMed]
129. Zhang, X.; Lu, Y. Centrifugal Spinning: An Alternative Approach to Fabricate Nanofibers at High Speed and
Low Cost. Polym. Rev. 2014, 54, 677–701. [CrossRef]
130. Medeiros, E.S.; Glenn, G.M.; Klamczynski, A.P.; Orts, W.J.; Mattoso, L.H.C. Solution blow spinning: A new
method to produce micro- and nanofibers from polymer solutions. J. Appl. Polym. Sci. 2009, 113, 2322–2330.
[CrossRef]
131. Gupta, K.C.; Haider, A.; Choi, Y.-R.; Kang, I.-K. Nanofibrous scaffolds in biomedical applications.
Biomater. Res. 2014, 18, 5. [CrossRef] [PubMed]
132. Matthews, J.A.; Wnek, G.E.; Simpson, D.G.; Bowlin, G.L. Electrospinning of Collagen Nanofibers.
Biomacromolecules 2002, 3, 232–238. [CrossRef] [PubMed]
133. Subramanian, A.; Krishnan, U.M.; Sethuraman, S. Fabrication of uniaxially aligned 3D electrospun scaffolds
for neural regeneration. Biomed. Mater. 2011, 6, 025004. [CrossRef] [PubMed]
134. Goh, Y.F.; Shakir, I.; Hussain, R. Electrospun fibers for tissue engineering, drug delivery, and wound dressing.
J. Mater. Sci. 2013, 48, 3027–3054. [CrossRef]
135. Zahedi, P.; Rezaeian, I.; Ranaei-Siadat, S.-O.; Jafari, S.-H.; Supaphol, P. A review on wound dressings with an
emphasis on electrospun nanofibrous polymeric bandages. Polym. Adv. Technol. 2010, 21, 77–95. [CrossRef]
136. Wharram, S.E.; Zhang, X.; Kaplan, D.L.; McCarthy, S.P. Electrospun silk material systems for wound healing.
Macromol. Biosci. 2010, 10, 246–257. [CrossRef] [PubMed]
137. Khadka, D.B.; Haynie, D.T. Protein- and peptide-based electrospun nanofibers in medical biomaterials.
Nanomedicine 2012, 8, 1242–1262. [CrossRef] [PubMed]
138. Taylor, G.I. Electrically driven jets. Proc. R. Soc. Lond. Ser. A 1969, 313, 453–475. [CrossRef]
139. Rho, K.S.; Jeong, L.; Lee, G.; Seo, B.-M.; Park, Y.J.; Hong, S.-D.; Roh, S.; Cho, J.J.; Park, W.H.; Min, B.-M.
Electrospinning of collagen nanofibers: Effects on the behavior of normal human keratinocytes and
early-stage wound healing. Biomaterials 2006, 27, 1452–1461. [CrossRef] [PubMed]
140. Pegg, C.E.; Jones, G.H.; Athauda, T.J.; Ozer, R.R.; Chalker, J.M. Facile preparation of ammonium
alginate-derived nanofibers carrying diverse therapeutic cargo. Chem. Commun. 2014, 50, 156–158. [CrossRef]
[PubMed]
141. Li, G.; Li, Y.; Chen, G.; He, J.; Han, Y.; Wang, X.; Kaplan, D.L. Silk-based biomaterials in biomedical textiles
and fiber-based implants. Adv. Healthc. Mater. 2015, 4, 1134–1151. [CrossRef] [PubMed]
142. Lee, K.H.; Baek, D.H.; Ki, C.S.; Park, Y.H. Preparation and characterization of wet spun silk fibroin/poly(vinyl
alcohol) blend filaments. Int. J. Biol. Macromol. 2007, 41, 168–172. [CrossRef] [PubMed]
143. Qiu, W.; Teng, W.; Cappello, J.; Wu, X. Wet-Spinning of Recombinant Silk-Elastin-Like Protein Polymer
Fibers with High Tensile Strength and High Deformability. Biomacromolecules 2009, 10, 602–608. [CrossRef]
[PubMed]
144. Sun, M.; Zhang, Y.; Zhao, Y.; Shao, H.; Hu, X. The structure–property relationships of artificial silk fabricated
by dry-spinning process. J. Mater. Chem. 2012, 22, 18372–18379. [CrossRef]
145. Tian, Q.; Xu, Z.; Liu, Y.; Fang, B.; Peng, L.; Xi, J.; Li, Z.; Gao, C. Dry spinning approach to continuous
graphene fibers with high toughness. Nanoscale 2017, 9, 12335–12342. [CrossRef] [PubMed]
146. Nain, A.; Wong, J.; Amon, C.; Sitti, M. Drawing suspended polymer micro-/nanofibers using glass
micropipettes. Appl. Phys. Lett. 2006, 89, 183105. [CrossRef]
147. Buzgo, M.; Rampichova, M.; Vocetkova, K.; Sovkova, V.; Lukasova, V.; Doupnik, M.; Mickova, A.;
Rustichelli, F.; Amler, E. Emulsion centrifugal spinning for production of 3D drug releasing nanofibres with
core/shell structure. RSC Adv. 2017, 7, 1215–1228. [CrossRef]
148. Weitz, R.T.; Harnau, L.; Rauschenbach, S.; Burghard, M.; Kern, K. Polymer Nanofibers via Nozzle-Free
Centrifugal Spinning. Nano Lett. 2008, 8, 1187–1191. [CrossRef] [PubMed]
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